[1] Khomich O, Ivanov A V, Bartosch B. Metabolic hallmarks of hepatic stellate sells in liver fibrosis. Cells,2019,9(1):24-29. [2] Pantano L, Agyapong G, Shen Y, et al. Molecular characterization and cell type composition deconvolution of fibrosis in NAFLD. Sci Rep,2021,11(1):18045. [3] Gheorghe G, Bungau S, Ceobanu G, et al. The non-invasive assessment of hepatic fibrosis. J Formos Med Assoc,2021,120(2):794-803. [4] 德吉,白玛,白央,等. CHB和肝硬化患者肝脏硬度检测值的变化及其影响因素分析. 实用肝脏病杂志,2019,22(3):401-404. [5] 李曼,张军,李涛,等. ADA/PLT、ALP/PLT比值比值对肝纤维化的诊断价值. 中国实验诊断学,2017,21(11):1923-1926. [6] 中国中西医结合学会肝病专业委员会. 肝纤维化中西医结合诊疗指南(2019年版). 中华肝脏病杂志,2019,27(7):494-504. [7] 江超,郭鲁,时丹丹,等. 二维剪切波弹性成像检测乳腺癌术后化疗患者肝弹性值变化的应用价值. 中华超声影像学杂志,2022,31(4):312-317. [8] Borro P, Ziola S, Pasta A, et al. Hepatic elastometry and glissonian Line in the assessment of liver fibrosis. Ultrasound Med Biol,2021,47(4):947-959. [9] Fuentes-Velez S, Fagoonee S, Sanginario A, et al. Electrical impedance-based characterization of hepatic tissue with early-stage fibrosis. Biosensors (Basel),2022,12(2):116-119. [10] Jin K, Wang H, Zeng M, et al. A comparative study of MR extracellular volume fraction measurement and two-dimensional shear-wave elastography in assessment of liver fibrosis with chronic hepatitis B. Abdom Radiol (NY),2019,44(4):1407-1414. [11] Chin J, Powell L W, Ramm L E, et al. Utility of serum biomarker indices for staging of hepatic fibrosis before and after venesection in patients with hemochromatosis caused by variants in HFE. Clin Gastroenterol Hepatol,2021,19(7):1459-1468. [12] Albillos A, Martin-Mateos R, Van der Merwe S, et al. Cirrhosis-associated immune dysfunction. Nat Rev Gastroenterol Hepatol,2022,19(2):112-134. [13] Kim M N, Lee J H, Chon Y E, et al. Fibrosis-4, aspartate transaminase-to-platelet ratio index, and gamma-glutamyl transpeptidase-to-platelet ratio for risk assessment of hepatocellular carcinoma in chronic hepatitis B patients: comparison with liver biopsy. Eur J Gastroenterol Hepatol,2020,32(3):433-439. [14] Dong B, Lyu G, Chen Y, et al. Comparison of two-dimensional shear wave elastography, magnetic resonance elastography, and three serum markers for diagnosing fibrosis in patients with chronic hepatitis b: a meta-analysis. Expert Rev Gastroenterol Hepatol,2021,15(9):1077-1089. [15] Baldea V, Sporea I, Tudor A, et al. Virtual touch quantification using acoustic radiation force impulse imaging technology versus transient elastography for the noninvasive assessment of liver fibrosis in patients with chronic hepatitis B or C using liver biopsy as the gold standard. J Gastrointestin Liver Dis,2020,29(2):181-190. [16] 杨艳秋,程颢,冯敏. 肝脏剪切波弹性成像对CHB患者肝纤维化的评估价值. 实用肝脏病杂志,2021,24(4):480-483. [17] Nabavizadeh A, Payen T, Iuga AC, et al. Noninvasive Young's modulus visualization of fibrosis progression and delineation of pancreatic ductal adenocarcinoma (PDAC) tumors using harmonic motion elastography (HME) in vivo. Theranostics,2020,10(10):4616-4626. [18] Gatselis NK, Goet JC, Zachou K, et al. Factors associated with progression and outcomes of early stage primary biliary cholangitis. Clin Gastroenterol Hepatol,2020,18(3):684-692. [19] Gold L C, Macpherson I, Nobes J H, et al. Thrombocytosis and abnormal liver enzymes: a trigger for investigation of underlying malignancy. PLoS One,2022,17(4):267-274. [20] Dong B, Huang S, Chang J, et al. Comparison of sound touch elastography, sound touch quantify, and 4 serum fibrosis indexes for the diagnosis of liver fibrosis in patients with chronic hepatitis B. Ultrasound Q,2021,37(2):123-128. [21] Cheng M Q, Hu H T, Huang H, et al. Pathological considerations of CEUS LI-RADS: correlation with fibrosis stage and tumour histological grade. Eur Radiol,2021,31(8):5680-5688. [22] 翟相威,刘树红,姚明解,等. 基于血清高尔基体蛋白73的代偿期乙型肝炎肝硬化无创诊断模型的建立及初步应用. 中华肝脏病杂志,2020,28(1):47-52. [23] Nielsen MJ, Leeming DJ, Goodman Z, et al. Comparison of ADAPT, FIB-4 and APRI as non-invasive predictors of liver fibrosis and NASH within the CENTAUR screening population. J Hepatol,2021,75(6):1292-1300. [24] Pan Y, Yang K, Sun B, et al. Application of alkaline phosphatasetoplatelet ratio as a novel noninvasive index predicts liver fibrosis in patients with chronic hepatitis B. Exp Ther Med,2022,24(4):619-692. [25] Pyo JY, Ahn SS, Lee LE, et al. The novel fibrosis index at diagnosis may predict all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis without substantial liver diseases. Clinics (Sao Paulo),2021,76(1):2501. |